VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance

U.S. Markets open in 5 hrs 30 mins

Vertex Pharmaceuticals Incorporated (VRTX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
81.55-1.62 (-1.95%)
At close: 4:00PM EST
People also watch
ALXNREGNBMRNBIIBINCY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close83.17
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range79.78 - 82.54
52 Week Range71.46 - 103.73
Volume1,332,171
Avg. Volume2,093,706
Market Cap20.23B
Beta1.80
PE Ratio (TTM)-71.91
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Why Vertex Pharmaceuticals Stock Sank 42% in 2016
    Motley Fool19 hours ago

    Why Vertex Pharmaceuticals Stock Sank 42% in 2016

    Slowing sales growth for its rare-disease drugs kept the market second-guessing the biotech's potential.

  • Merck KGaA, Vertex Announce Tie-Up for Oncology Programs
    Zacks6 days ago

    Merck KGaA, Vertex Announce Tie-Up for Oncology Programs

    Merck (MKGAF) and Vertex (VRTX) collaborated for the development and commercialization of four research and development programs for the treatment of cancer.

  • Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : January 11, 2017
    Capital Cube7 days ago

    Vertex Pharmaceuticals, Inc. – Value Analysis (NASDAQ:VRTX) : January 11, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives Vertex Pharmaceuticals, Inc. a score of 28. Our analysis is based on comparing Vertex Pharmaceuticals, Inc. with the following peers – Gilead Sciences, Inc., AbbVie, Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Enzon Pharmaceuticals, Inc., Enanta Pharmaceuticals, Inc. and SciClone Pharmaceuticals, Inc. (GILD-US, ... Read more (Read more...)